Solid-Phase Bioconjugation of Heterobifunctional Adaptors for Versatile Assembly of Bispecific Targeting Ligands
Open Access
- 10 July 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 25 (8) , 1511-1516
Abstract
High-throughput generation of bispecific molecules promises to expedite the discovery of new molecular therapeutics and guide engineering of novel multifunctional constructs. However, high synthesis complexity and cost have hampered the discovery of bispecific molecules in drug development and biomedical research. Herein we describe a simple solid-phase bioconjugation procedure for preparation of Protein A(G,L)-PEG-Streptavidin heterobifunctional adaptors (with 1:1:1 stoichiometry), which enable self-assembly of unmodified antibodies and biotinylated molecules into bispecific targeting ligands in a versatile mix-and-use manner. Utility of such adaptors is demonstrated by assembly of anti-CD3 and anti-Her2 antibodies into bispecific CD3xHer2 targeting ligands, which efficiently drive T-cell-mediated lysis of Her2-positive cancer cells. In comparison to bioconjugation in solution, the solid-phase procedure described here offers precise stoichiometry control, ease of purification, and high yield of functional conjugates. Simplicity and versatility should prove this methodology instrumental for preparation of bispecific ligands, as well as for high-throughput screening of bispecific combinations, before proceeding to synthesis of lead candidates via recombinant engineering or chemical cross-linking.Keywords
Funding Information
- National Institutes of Health (F32CA150301, R01CA140295, T32CA138312)
This publication has 28 references indexed in Scilit:
- Assembly of Protein Building Blocks Using a Short Synthetic PeptideBioconjugate Chemistry, 2012
- Bispecific digoxigenin-binding antibodies for targeted payload deliveryProceedings of the National Academy of Sciences, 2011
- Engineering Monovalent Quantum Dot−Antibody Bioconjugates with a Hybrid Gel SystemBioconjugate Chemistry, 2011
- Antibody–drug conjugates for cancer: poised to deliver?Nature Reviews Drug Discovery, 2010
- Multivalent antibodies: when design surpasses evolutionTrends in Biotechnology, 2010
- Solid-Phase PEGylation of Recombinant Interferon α-2a for Site-Specific Modification: Process Performance, Characterization, andin VitroBioactivityBioconjugate Chemistry, 2007
- The Origins of Femtomolar Protein−Ligand Binding: Hydrogen-Bond Cooperativity and Desolvation Energetics in the Biotin−(Strept)Avidin Binding SiteJournal of the American Chemical Society, 2007
- Identification of Quantum Dot Bioconjugates and Cellular Protein Co-localization by Hybrid Gel BlottingNano Letters, 2007
- Self-Assembled “Dock and Lock” System for Linking Payloads to Targeting ProteinsBioconjugate Chemistry, 2006
- Preparation of Bispecific Antibodies by Chemical Recombination of Monoclonal Immunoglobulin G 1 FragmentsScience, 1985